Abstract Submission

The American College of Rheumatology and Association of Rheumatology Professionals invite you to submit an abstract to ACR Convergence and take advantage of the opportunity to have your work peer reviewed by experts in the field.

Abstract Submission Is Open

Abstract submission is open. The abstraction submission site will close on June 1, noon ET.

Submit Abstract

Abstract Submission Eligibility

Persons Eligible to Submit
Members and non-members of the ACR and ARP are eligible to submit an abstract.

Abstracts Eligible for Submission

  • Abstracts that have been previously accepted and/or presented at other medical meetings are eligible for submission. These abstracts will go through the same peer review process as any other abstracts.
  • Abstracts describing original basic and clinical science related to the broad area of rheumatic diseases may be submitted.
  • Abstracts reporting results of a clinical trial will be required to identify the trial phase.
  • Any work with human or animal subjects reported in submitted abstracts must comply with the guiding principles for experimental procedures found in the Declaration of Helsinki of the World Medical Association.

Abstracts Not Eligible for Submission

  • Abstracts should not report results that have been previously presented at ACR Convergence.
  • Abstracts that report work that has been accepted for publication as a manuscript (e.g., full-length article, brief report, case report, concise communication or letter to the editor, etc.) prior to the ACR/ARP submission deadline of noon ET on June 1, 2021 are ineligible for consideration.
  • Multiple abstracts may not be submitted for one study unless substantially different research questions are being addressed in each abstract.
  • Abstracts submitted for the ARP program may not be concurrently submitted to the ACR program.
  • Case reports are not considered appropriate and will not be reviewed. We encourage those with interesting cases or images to consider submission to the Thieves Market or Image Competition. See separate submission processes.
  • Abstracts not accepted in the main abstract review submission should not be re-submitted to the late-breaking category.

Abstract Submission Guidelines

Download the 2021 Call for Abstracts Guidelines.

ACR Abstracts
The ACR seeks abstracts on the following topics:

  • Clinical practice of rheumatology
  • Teaching of rheumatology
  • Basic and translational science that contributes to the understanding of disease pathogenesis
  • Mechanisms and efficacy of therapeutics
  • Delivery of healthcare to patients with musculoskeletal and rheumatic disease

Abstract Submission Timeline

  • Abstract submission: April 13 - June 1
  • Author notification: Late August
  • Late-breaking abstract submission: August 31 - September 28
  • Late-breaking author notification: Mid October

Abstract Withdrawal

After the abstract submission period closes, presenting authors may submit a request to have an abstract withdrawn.

Withdrawal requests must be submitted by the presenting author by email to withdrawn@rheumatology.org and include the following:

  • Abstract ID number
  • Abstract title
  • Presenting author’s name

Removal of a withdrawn abstract from the online supplement of Arthritis & Rheumatology cannot be guaranteed if the request was received after (date to be announced).

Withdrawal or rejection of an abstract will not result in the refund of a submission fee. All submission fees are non-refundable.